ICE-R regimen

	WikiDoc Resources for ICE-R regimen
Articles
Most recent articles on ICE-R regimen Most cited articles on ICE-R regimen Review articles on ICE-R regimen Articles on ICE-R regimen in N Eng J Med, Lancet, BMJ
Media
Powerpoint slides on ICE-R regimen Images of ICE-R regimen Photos of ICE-R regimen Podcasts & MP3s on ICE-R regimen Videos on ICE-R regimen
Evidence Based Medicine
Cochrane Collaboration on ICE-R regimen Bandolier on ICE-R regimen TRIP on ICE-R regimen
Clinical Trials
Ongoing Trials on ICE-R regimen at Clinical Trials.gov Trial results on ICE-R regimen Clinical Trials on ICE-R regimen at Google
Guidelines / Policies / Govt
US National Guidelines Clearinghouse on ICE-R regimen NICE Guidance on ICE-R regimen NHS PRODIGY Guidance FDA on ICE-R regimen CDC on ICE-R regimen
Books
Books on ICE-R regimen
News
ICE-R regimen in the news Be alerted to news on ICE-R regimen News trends on ICE-R regimen
Commentary
Blogs on ICE-R regimen
Definitions
Definitions of ICE-R regimen
Patient Resources / Community
Patient resources on ICE-R regimen Discussion groups on ICE-R regimen Patient Handouts on ICE-R regimen Directions to Hospitals Treating ICE-R regimen Risk calculators and risk factors for ICE-R regimen
Healthcare Provider Resources
Symptoms of ICE-R regimen Causes & Risk Factors for ICE-R regimen Diagnostic studies for ICE-R regimen Treatment of ICE-R regimen
Continuing Medical Education (CME)
CME Programs on ICE-R regimen
International
ICE-R regimen en Espanol ICE-R regimen en Francais
Business
ICE-R regimen in the Marketplace Patents on ICE-R regimen
Experimental / Informatics
List of terms related to ICE-R regimen

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Aparna Vuppala, M.B.B.S. [2]

Synonyms and keywords:R-ICE Regimen; RICE Regimen; Rituximab-Ifosfamide-Carboplatin-Etoposide Regimen

Overview[edit | edit source]

ICE-R regimen refers to a chemoimmunotherapy regimen consisting of rituximab, ifosfamide, carboplatin and etoposide used to treat indolent and aggressive forms of non-Hodgkin's lymphoma; also used to treat relapsed and refractory non-Hodgkin's lymphoma.^[1]^[2]

Regimen[edit | edit source]

RRituximab

IIfosfamide

CCarboplatin

EEtoposide

Indications[edit | edit source]

Relapsed and refractory non-Hodgkin's lymphoma.^[1]

References[edit | edit source]

↑ ^1.0 ^1.1 Vose J, Sneller V (2003). "Outpatient regimen rituximab plus ifosfamide, carboplatin and etoposide (R-ICE) for relapsed non-Hodgkin's lymphoma". Ann Oncol. 14 Suppl 1: i17–20. PMID 12736226.
↑ "NCI Thesaurus".

[pmid12736226-1] 1.0 ^1.1 Vose J, Sneller V (2003). "Outpatient regimen rituximab plus ifosfamide, carboplatin and etoposide (R-ICE) for relapsed non-Hodgkin's lymphoma". Ann Oncol. 14 Suppl 1: i17–20. PMID 12736226.

[2] "NCI Thesaurus".

[1]

[2]